Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director | November 05, 2025 | November 07, 2025 |
| DAVITA INC.DVA · Entity 3482 | CFO and Treasurer | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2035-11-05 | Direct | 21,216 |
Reported balance
After 2025-11-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 21,216 · Balance 21,216 F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.
DAVITA INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,434 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Sale · Disposed 51,471 · Balance 132,434 F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sale price of $192.099. The range of prices for the sale of these shares was $191.510 - $192.765 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KINDRED HEALTHCARE, INC
Report date July 02, 2018 · Filed July 02, 2018
Section 16 reporting ended · disclosed 2018-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-02 transaction · row 1
1 source rowRow 1 · 2018-07-02 · Disposition to issuer · Disposed 75,167 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2023 Filed May 13, 2023 00:44 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 56,306 | $0.00 Strike: $66.29 | $0.00 |
DisclosureSEC source: 0000927066-23-000107 · wk-form4_1683938681.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,306 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on May 15, 2018, which vested 50% each on May 15, 2021 and May 15, 2022. Read SEC document |
| May 10, 2023 Filed May 13, 2023 00:44 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 9,826 | $100.72 | $989,674.72 |
DisclosureSEC source: 0000927066-23-000107 · wk-form4_1683938681.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,212 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| May 10, 2023 Filed May 13, 2023 00:44 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 37,059 | $100.72 | $3,732,582.48 |
DisclosureSEC source: 0000927066-23-000107 · wk-form4_1683938681.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,038 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| May 10, 2023 Filed May 13, 2023 00:44 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 56,306 | $66.29 | $3,732,524.74 |
DisclosureSEC source: 0000927066-23-000107 · wk-form4_1683938681.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 21:27 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 2,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000075 · wf-form4_168081646489988.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,791 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019, of which 100% will vest on May 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:17 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 709 | $76.04 | $53,912.36 |
DisclosureSEC source: 0000927066-23-000067 · wf-form4_167909502243979.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,001 F3 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 1,387 shares, which represents 100% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:17 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 4,260 | $76.04 | $323,930.40 |
DisclosureSEC source: 0000927066-23-000067 · wf-form4_167909502243979.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,710 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 8,343 shares, which represents 100% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 23:17 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 23,672 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000067 · wf-form4_167909502243979.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,970 F1 · shares: These restricted stock units are scheduled to vest 50% each on March 15, 2026 and March 15, 2027, subject to continued service through each applicable vesting date. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 22:04 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000030 · wf-form4_167874503349958.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,298 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020, of which 100% will vest on March 15, 2023. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 23:19 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 8,343 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000018 · wf-form4_167753989462507.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,911 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020, of which 100% will vest on March 15, 2023. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 23:19 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 22,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000018 · wf-form4_167753989462507.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,568 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019, of which 100% will vest on May 15, 2023. Read SEC document |
| November 01, 2022 Filed Aug 17, 2023 16:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 26,500 | $7.00 Strike: $7.00 | $185,500.00 |
DisclosureSEC source: 0001628280-23-029779 · wf-form4_169228859069507.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2032-11-01 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively. Read SEC document |
| October 19, 2022 Filed Oct 20, 2022 17:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 16,667 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001628280-22-026743 · wf-form4_166628679804291.xml · derivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires 2022-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, respectively. Read SEC document |
| October 19, 2022 Filed Oct 20, 2022 17:26 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 16,667 | $3.21 | $53,501.07 |
DisclosureSEC source: 0001628280-22-026743 · wf-form4_166628679804291.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2022 Filed May 17, 2022 22:16 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 7,624 | $100.05 | $762,781.20 |
DisclosureSEC source: 0000927066-22-000104 · wf-form4_165282574827686.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,168 F4 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 14,934 shares, which represents 50% of the restricted stock units granted to the Reporting Person on May 15, 2019. Read SEC document |
| May 15, 2022 Filed May 17, 2022 22:16 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 14,082 | $100.05 | $1,408,904.10 |
DisclosureSEC source: 0000927066-22-000104 · wf-form4_165282574827686.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,792 F3 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 28,385 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019. Read SEC document |
| May 15, 2022 Filed May 17, 2022 22:16 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 2,875 | $100.05 | $287,643.75 |
DisclosureSEC source: 0000927066-22-000104 · wf-form4_165282574827686.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,874 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 5,631 shares, which represents the remaining 50% of the restricted stock units granted to the Reporting Person on May 15, 2018. Read SEC document |
| May 15, 2022 Filed May 17, 2022 22:16 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 9,414 | $100.05 | $941,870.70 |
DisclosureSEC source: 0000927066-22-000104 · wf-form4_165282574827686.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,749 F1 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 18,438 shares, which represents the remaining 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 23:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 28,385 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000055 · wf-form4_165058253538010.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,163 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2019, of which 100% will vest on May 15, 2022. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 23:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 18,438 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000055 · wf-form4_165058253538010.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,778 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018, of which 100% will vest on May 15, 2022. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:34 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock · Derivative | 43,388 | $0.00 Strike: $110.63 | $0.00 |
DisclosureSEC source: 0000927066-22-000038 · wf-form4_164754924324089.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,388 Underlying: Common Stock · 43,388 shares Expires 2027-03-15 F1 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% each on March 15, 2025 and March 15, 2026, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:30 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 18,564 | $10.10 Strike: $10.10 | $187,496.40 |
DisclosureSEC source: 0001628280-21-022604 · wf-form4_163649701340351.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,564 Underlying: Common Stock · 18,564 shares Expires 2031-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:32 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionStock Appreciation Rights · Derivative | 145,159 | $0.00 Strike: $68.89 | $0.00 |
DisclosureSEC source: 0000927066-21-000138 · wf-form4_162872475869879.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 145,159 shares Expires 2022-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on February 21, 2017, which vested 50% each on February 21, 2020 and February 21, 2021. F4 · derivative.expiration_date: Expiration date incorrectly reported as February 21, 2021 on Form 4/A filed on February 23, 2017. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:32 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 37,226 | $133.17 | $4,957,386.42 |
DisclosureSEC source: 0000927066-21-000138 · wf-form4_162872475869879.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,340 F2 · shares: Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:32 UTC | DAVITA INC. DVA · Entity 3482 | Disposition to issuerCommon Stock | 75,093 | $133.17 | $10,000,134.81 |
DisclosureSEC source: 0000927066-21-000138 · wf-form4_162872475869879.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,566 F1 · shares: Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 23:32 UTC | DAVITA INC. DVA · Entity 3482 | Exercise / conversionCommon Stock | 145,159 | $68.89 | $10,000,003.51 |
DisclosureSEC source: 0000927066-21-000138 · wf-form4_162872475869879.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 22:00 UTC | DAVITA INC. DVA · Entity 3482 | SaleCommon Stock | 37,760 | $131.36 | $4,960,146.05 |
DisclosureSEC source: 0001206774-21-002054 · ackerman3942851-form4.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · price: Represents the weighted average sale price of $131.3598. The range of prices for the sale of these shares was $130.0000 - $131.8300 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:57 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 8,272 | $125.41 | $1,037,391.52 |
DisclosureSEC source: 0000927066-21-000110 · wf-form4_162138582064301.xml · nonDerivative · entry 5 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,260 F5 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 16,894 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:57 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 1,419 | $125.41 | $177,956.79 |
DisclosureSEC source: 0000927066-21-000110 · wf-form4_162138582064301.xml · nonDerivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,532 F4 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 2,899 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:57 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 2,756 | $125.41 | $345,629.96 |
DisclosureSEC source: 0000927066-21-000110 · wf-form4_162138582064301.xml · nonDerivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,951 F3 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 5,630 shares, which represents 50% of the restricted stock units granted to the Reporting Person on May 15, 2018. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:57 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 11,180 | $125.41 | $1,402,083.80 |
DisclosureSEC source: 0000927066-21-000110 · wf-form4_162138582064301.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,707 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 22,832 shares, which represents 100% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on June 6, 2017. Read SEC document |
| May 15, 2021 Filed May 19, 2021 00:57 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 712 | $125.41 | $89,291.92 |
DisclosureSEC source: 0000927066-21-000110 · wf-form4_162138582064301.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,887 F1 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 1,456 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on June 6, 2017. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 23:17 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 2,899 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000065 · wf-form4_161904701693153.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,599 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018, of which 100% will vest on May 15, 2021. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 23:17 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 1,456 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000065 · wf-form4_161904701693153.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,700 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on June 6, 2017, of which 100% will vest on May 15, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:41 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 44,065 | $0.00 Strike: $108.93 | $0.00 |
DisclosureSEC source: 0000927066-21-000053 · wf-form4_161601724995995.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,065 Underlying: Common Stock · 44,065 shares Expires 2026-03-15 F1 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% each on March 15, 2024 and March 15, 2025, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 23:59 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 16,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000026 · wf-form4_161464317613528.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,244 F2 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on May 15, 2018, of which 100% will vest on May 15, 2021. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 23:59 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 22,832 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-21-000026 · wf-form4_161464317613528.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,350 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on June 6, 2017, of which 100% will vest on May 15, 2021. Read SEC document |
| December 19, 2020 Filed Dec 22, 2020 00:12 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 4,890 | $115.36 | $564,110.40 |
DisclosureSEC source: 0000927066-20-000272 · wf-form4_160859593585502.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,518 F1 · shares: Shares withheld from issuance to satisfy tax withholding obligations in connection with the vesting of 11,300 shares, which represents 50% of the shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 28, 2018, in which 11,301 shares vested on June 19, 2019 and the remaining 11,300 vested on December 19, 2020. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:00 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 16,667 | $11.96 Strike: $11.96 | $199,337.32 |
DisclosureSEC source: 0001628280-20-017366 · wf-form4_160763762160042.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2025-12-08 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on December 8, 2020, March 8, 2021, June 8, 2021 and September 8, 2021, respectively. Read SEC document |
| May 15, 2020 Filed May 20, 2020 01:10 UTC | DAVITA INC. DVA · Entity 3482 | Tax withholdingCommon Stock | 425 | $79.25 | $33,681.25 |
DisclosureSEC source: 0000927066-20-000093 · wf-form4_158993701814685.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,408 F2 · shares: Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 1,116 shares as described in footnote 1 above. Read SEC document |
| May 15, 2020 Filed May 20, 2020 01:10 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 1,116 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-20-000093 · wf-form4_158993701814685.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,833 F1 · shares: Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on June 6, 2017. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 23:56 UTC | DAVITA INC. DVA · Entity 3482 | GrantStock Appreciation Rights · Derivative | 78,999 | $0.00 Strike: $75.95 | $0.00 |
DisclosureSEC source: 0000927066-20-000048 · wf-form4_158448934752846.xml · derivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · CFO and Treasuer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,999 Underlying: Common Stock · 78,999 shares Expires 2025-03-15 F1 · derivative.exercise_date: The stock appreciation rights are scheduled to vest 50% on each of March 15, 2023 and March 15, 2024, respectively, subject to the terms and conditions of the applicable award agreement. Read SEC document |
| March 03, 2020 Filed Nov 3, 2020 22:46 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 2,708 | $4.80 Strike: $4.80 | $12,998.40 |
DisclosureSEC source: 0001628280-20-015402 · wf-form4_160444355106654.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on March 13, 2015. Read SEC document |
| March 03, 2020 Filed Nov 3, 2020 22:46 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 124,232 | $5.76 Strike: $5.76 | $715,576.32 |
DisclosureSEC source: 0001628280-20-015402 · wf-form4_160444355106654.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 124,232 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on March 13, 2015. Read SEC document |
| March 03, 2020 Filed Nov 3, 2020 22:46 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 2,708 | $4.80 | $12,998.40 |
DisclosureSEC source: 0001628280-20-015402 · wf-form4_160444355106654.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Nov 3, 2020 22:46 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 124,232 | $5.76 | $715,576.32 |
DisclosureSEC source: 0001628280-20-015402 · wf-form4_160444355106654.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 1,521 | $2.10 Strike: $2.10 | $3,194.10 |
DisclosureSEC source: 0001628280-19-014734 · wf-form4_157549384127236.xml · derivative · entry 4 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2023-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19,2016 Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 201,590 | $2.10 Strike: $2.10 | $423,339.00 |
DisclosureSEC source: 0001628280-19-014734 · wf-form4_157549384127236.xml · derivative · entry 3 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 201,590 shares Expires 2020-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options were immediately exercisable upon grant on July 19,2016 Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 1,521 | $2.10 | $3,194.10 |
DisclosureSEC source: 0001628280-19-014734 · wf-form4_157549384127236.xml · nonDerivative · entry 2 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 201,590 | $2.10 | $423,339.00 |
DisclosureSEC source: 0001628280-19-014734 · wf-form4_157549384127236.xml · nonDerivative · entry 1 ACKERMAN JOEL · CIK 0001220630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.